Emily Klein, Director of Venture Development

Feb. 9, 2022

Emily joins Venture Partners from Rockies Venture Club where she supported early-stage entrepreneurs and angel investors across the US.


"Click" Thermoplastic Polymers - An easier and more efficient method to make robust and recyclable thermoplastics

Jan. 20, 2022

A method for the generation of high molecular weight polymers in an efficient, rapid, and facile manner.


Endoculus technology offers efficient and pain-free colonoscopy procedures

Jan. 20, 2022

A multi-DOF sensor-enabled robotic capsule endoscope for painless colonoscopy procedures that are both time and cost effective.


Vehicle diagnostics through car batteries offer protection against cyber risks

Jan. 20, 2022

A system that diagnoses vehicle anomalies by cross-validating data from traditional vehicle diagnostics and changes in battery voltage


Meet the Venture Partners team: Kayle Lingo

Jan. 19, 2022

Say hello to Senior Marketing & Communications Specialist Kayle Lingo, who's been with the Venture Partners team for three months. A lifelong Coloradan, Kayle joined Venture Partners from CU System Employee Services. She loves weightlifting, cooking and doing jigsaw puzzles.

Lynn Pae

Meet the Venture Partners team: Lynn Pae

Dec. 13, 2021

Say hello to License Administrator Lynn Pae, who's been with the Venture Partners team for 19 years. Originally from the DC area, she moved to Colorado with her husband after 17 years in Florida. She loves the mountains, paddle boarding and cooking.


Novel therapeutic use of peptidoglycan muropeptides to promote ATP synthase activity and mitochondrial homeostasis

Dec. 13, 2021

An effective therapy to boost ATP synthase activity and promote mitochondrial homeostasis.

Adjustable R-value Insulation Systems

Adjustable R-value Insulation Systems

Dec. 13, 2021

A technology enabling an adjustable R-value for insulation systems depending on conditions, reducing energy use significantly.

Hannah Nelson

Meet the Venture Partners team: Hannah Nelson

Nov. 17, 2021

Say hello to Licensing Analyst Hannah Nelson, who's been with the Venture Partners team for one year. Originally from the Midwest, she received a degree in Biology from Trinity University and a Ph.D. in Microbiology at the University of Texas at Austin before moving to Colorado this past year.


Chimeric Cas12a-type Nucleases for CRISPR Gene Editing

Nov. 17, 2021

New CRISPR/Cas12a-type nucleases with improved characteristics for targeted editing.